-
HIV-positive women have a much higher risk of developing cervical and uterine cancers than do women without the disease, due to their impaired immune function.
-
When it comes to HIV/AIDS, the nation's capitol is experiencing some of the highest rates in the United States. At least 3% of District of Columbia (DC) residents have HIV or AIDS, according to a 2009 epidemiology report by the DC HIV/AIDS office.
-
If your clinical practice includes care of college-age youth, you will want to review the results of a new study of university students.
-
Half of urban teenage girls may acquire at least one of three common sexually transmitted diseases (STDs) chlamydia, gonorrhea, or trichomoniasis within two years of becoming sexually active, according to results of a recent study.
-
BP response of atenolol vs HCTZ; Ipratropium and CV events in COPD; Kidney function, proteinuria, and adverse outcomes; Remission of diabetes with bariatric surgery; Inhaled cortico-steroids and COPD exacerbations; Non-alcoholic fatty liver disease in Japanese patients
-
When Contraceptive Technology Update began publication in 1980, U.S. women had few choices when it came to birth control.
-
You've discussed the latest birth control options with your female patient and touched on information on the contraceptive patch, vaginal ring, implant, and injection, as well as intrauterine contraception, barrier methods, and abstinence.
-
When not constrained by your clinic's formulary, which oral contraceptive (OC) do you pick for a 21-year-old nonsmoking woman? Look to Ortho Tri-Cyclen Lo (Ortho-McNeil Pharmaceutical; Raritan, NJ), which continues its No. 1 spot in the 2009 Contraceptive Technology Update Contraception Survey.
-
The next woman in your exam room says she has had cramping, breast tenderness, and headaches during the pill-free placebo week of her oral contraceptive (OC). She is open to having less frequent withdrawal bleeding. What's your next move?
-
This issue marks the 30th anniversary of Contraceptive Technology Update.
